Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Naproxen

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 4 (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04694300Phase 4CompletedPrimary

OTC Naproxen and Acetaminophen Anti-Inflammatory Action in Dental Implant Patients

NCT02349620Phase 2UnknownPrimary

Effect of Platelet-rich Factor on Implant Stability and Bone Resorption in the Lower Posterior Mandible

Showing all 2 trials

Research Network

Common Treatments

  • Naproxen1
  • Acetaminophen1
  • Tramadol1
  • Prf1

Active Sponsors

  • Hersh, Elliot V., DMD, MS, PhD1
  • Reza Tabrizi1
  • University of Pennsylvania1

Top Investigators

Related Conditions

  • Pain Acute1

Activity Timeline